Well-defined melanoma antigens as progression markers for melanoma: insights into differential expression and host response based on stage.
Hodi
F Stephen
FS
Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts 02115, USA. stephen_hodi@dfci.harvard.edu
D000818:Animals; D000951:Antigens, Neoplasm / Q000235:genetics* / Q000276:immunology*; D014408:Biomarkers, Tumor / Q000235:genetics* / Q000276:immunology*; D019496:Cancer Vaccines / Q000276:immunology / Q000627:therapeutic use; D018450:Disease Progression; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D008545:Melanoma / Q000235:genetics* / Q000276:immunology* / Q000628:therapy
D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; D019496:Cancer Vaccines